Review



dx eplex blood culture identification gram-negative (bcid-gn) panel  (GenMark Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenMark Diagnostics dx eplex blood culture identification gram-negative (bcid-gn) panel
    Dx Eplex Blood Culture Identification Gram Negative (Bcid Gn) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dx eplex blood culture identification gram-negative (bcid-gn) panel/product/GenMark Diagnostics
    Average 90 stars, based on 1 article reviews
    dx eplex blood culture identification gram-negative (bcid-gn) panel - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    dx eplex blood culture identification gram-negative (bcid-gn) panel  (GenMark Diagnostics)
    90
    GenMark Diagnostics dx eplex blood culture identification gram-negative (bcid-gn) panel
    Dx Eplex Blood Culture Identification Gram Negative (Bcid Gn) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dx eplex blood culture identification gram-negative (bcid-gn) panel/product/GenMark Diagnostics
    Average 90 stars, based on 1 article reviews
    dx eplex blood culture identification gram-negative (bcid-gn) panel - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    dx eplex bcid gram-negative (gn) panel  (GenMark Diagnostics)
    90
    GenMark Diagnostics dx eplex bcid gram-negative (gn) panel
    Dx Eplex Bcid Gram Negative (Gn) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dx eplex bcid gram-negative (gn) panel/product/GenMark Diagnostics
    Average 90 stars, based on 1 article reviews
    dx eplex bcid gram-negative (gn) panel - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    dx eplex investigational-use-only (iuo) blood culture identification gram-negative panel (bcid-gn)  (GenMark Diagnostics)
    90
    GenMark Diagnostics dx eplex investigational-use-only (iuo) blood culture identification gram-negative panel (bcid-gn)
    Dx Eplex Investigational Use Only (Iuo) Blood Culture Identification Gram Negative Panel (Bcid Gn), supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dx eplex investigational-use-only (iuo) blood culture identification gram-negative panel (bcid-gn)/product/GenMark Diagnostics
    Average 90 stars, based on 1 article reviews
    dx eplex investigational-use-only (iuo) blood culture identification gram-negative panel (bcid-gn) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    dx eplex blood culture identification (bcid) gram-negative (bcid-gn) panel  (GenMark Diagnostics)
    90
    GenMark Diagnostics dx eplex blood culture identification (bcid) gram-negative (bcid-gn) panel
    Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
    Dx Eplex Blood Culture Identification (Bcid) Gram Negative (Bcid Gn) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dx eplex blood culture identification (bcid) gram-negative (bcid-gn) panel/product/GenMark Diagnostics
    Average 90 stars, based on 1 article reviews
    dx eplex blood culture identification (bcid) gram-negative (bcid-gn) panel - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    dx bcid-gn panel  (GenMark Diagnostics)
    90
    GenMark Diagnostics dx bcid-gn panel
    Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
    Dx Bcid Gn Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dx bcid-gn panel/product/GenMark Diagnostics
    Average 90 stars, based on 1 article reviews
    dx bcid-gn panel - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

    doi: 10.1128/AAC.00441-21

    Figure Lengend Snippet: Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

    Article Snippet: The GenMark Dx ePlex blood culture identification (BCID) (research use only) Gram-positive (BCID-GP) and Gram-negative (BCID-GN) panels were used for retained blood samples that were frozen at −80°C.

    Techniques: Comparison

    Comparison of RDT platforms

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

    doi: 10.1128/AAC.00441-21

    Figure Lengend Snippet: Comparison of RDT platforms

    Article Snippet: The GenMark Dx ePlex blood culture identification (BCID) (research use only) Gram-positive (BCID-GP) and Gram-negative (BCID-GN) panels were used for retained blood samples that were frozen at −80°C.

    Techniques: Comparison, Bacteria